Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-Sestamibi

European Heart Journal Cardiovascular Imaging

Volumn 15, Issue 2, 2014, Pages 216-225

  Hadamitzky, Martin ^a   Langhans, Birgit ^a,b   Hausleiter, Jörg ^b   Sonne, Carolin ^a   Byrne, Robert A ^a   Mehilli, Julinda ^b   Kastrati, Adnan ^a   Schömig, Albert ^a   Martinoff, Stefan ^a   Ibrahim, Tareq ^c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cardiovascular magnetic resonance imaging; Myocardial infarction; Prognosis; Tc99m Sestamibi SPECT

Indexed keywords

CREATININE; GADOLINIUM PENTETATE MEGLUMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TROPONIN;

ACUTE HEART INFARCTION; ADULT; ANGIOPLASTY; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIAC PATIENT; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HIGH RISK POPULATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SCANNER; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVASCULARIZATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPECT SCANNER; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

CARDIOVASCULAR MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; PROGNOSIS; TC99M-SESTAMIBI SPECT;

ANGIOPLASTY, BALLOON, CORONARY; CONTRAST MEDIA; ELECTROCARDIOGRAPHY; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; RECURRENCE; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84892935621     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jet176     Document Type: Article

References (39)

1. Gibbons RJ, Valeti US, Araoz PA. The quantification of infarct size. J Am Coll Cardiol 2004;44:1533-42.
2. Miller TD, Christian TF, Hopfenspirger MR. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 1995;92:334-41.
3. Miller TD, Hodge DO, Sutton JM. Usefulness of technetium-99 m sestamibi infarct size in predicting posthospital mortality following acute myocardial infarction. Am J Cardiol 1998;81:1491-3.
4. Ibrahim T, Bulow HP, Hackl T. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction.JAm Coll Cardiol 2007;49: 208-16.
5. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979;28:1039-57.
6. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269: 3015-23.
7. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults(Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
8. Whelton PK. Epidemiology of hypertension. Lancet 1994;344:101-6.
9. Morrow DA, Antman EM, Charlesworth A. TIMI Risk score for ST-elevation myo-cardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000;102:2031-7.
10. Fox KA, Dabbous OH, Goldberg RJ. Predictionofriskofdeath and myocardial infarc-tioninthe six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 2006;333:1091.
11. Schomig A, Kastrati A, Dirschinger J. Coronarystenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activatorin acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med 2000;343:385-91.
12. Nekolla SG, Miethaner C, Nguyen N. Reproducibility of polar map generation and assessment of defect severity and extent assessment in myocardial perfusion imaging using positron emission tomography. Eur J Nucl Med 1998;25:1313-21.
13. O'Connor MK, Gibbons RJ, Juni JE. Quantitative myocardial SPECT for infarct sizing: feasibility of a multicenter trial evaluated using a cardiac phantom. J Nucl Med 1995; 36:1130-6.
14. Bondarenko O, Beek AM, Hofman MB. Standardizing the definition of hyperen-hancement in the quantitative assessment of infarct size and myocardial viability using delayed contrast-enhanced CMR. J Cardiovasc Magn Reson 2005;7:481-5.
15. Amado LC, Gerber BL, Gupta SN. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004;44:2383-9.
16. de Waha S, Desch S, Eitel I. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur Heart J 2010;31:2660-8.
17. Cochet AA, Lorgis L, Lalande A. Major prognostic impactofpersistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reper-fused acute myocardial infarction. Eur Radiol 2009;19:2117-26.
18. Kushner FG, Hand M, Smith SC Jr. 2009 Focused Updates:ACC/AHAGuidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and2007 Focused Update)and ACC/AHA/SCAI Guidelineson Per-cutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009;120: 2271-306.
19. R-Development-Core-Team. R: A Language and Environment for Statistical Computing. http://www.R-project.org.
20. Harrell F. The rms Package for R: Regression Modeling Strategies. http://biostat.mc. vanderbilt.edu/wiki/Main/Rrms.
21. Kastrati A, Mehilli J, Schlotterbeck K. Early administrationofreteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. JAMA 2004;291: 947-54.
22. Schomig A, Mehilli J, Antoniucci D. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 2005;293:2865-72.
23. Zohlnhofer D, Ott I, Mehilli J. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 2006;295:1003-10.
24. Ott I, Schulz S, Mehilli J. Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial. Circ Cardiovasc Interv 2010;3:408-13.
25. Lund GK, Stork A, Saeed M. Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. Radiology 2004;232:49-57.
26. Wagner A, Mahrholdt H, Holly TA. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-9.
27. Wu KC, Zerhouni EA, Judd RM. Prognostic significanceofmicrovascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-72.
28. Eitel I, Desch S, Fuernau G. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance inacute reperfused myocar-dial infarction. J Am Coll Cardiol 2010;55:2470-9.
29. Hundley WG, Bluemke D, Bogaert JG. Society for cardiovascular magnetic resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson 2009;11:5.
30. Schulz-Menger J, Bluemke DA, Bremerich J. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force onstandardized post processing. J Cardiovasc Magn Reson 2013;15:35.
31. Beek AM, Nijveldt R, van Rossum AC. Intramyocardial hemorrhage and microvascu-lar obstruction after primary percutaneous coronary intervention. Int J Cardiovasc Imaging 2010;26:49-55.
32. Kim RJ, Fieno DS, Parrish TB. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100: 1992-2002.
33. Saeed M, Lund G, Wendland MF. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 2001;103:871-6.
34. Engblom H, Hedstrom E, Heiberg E. Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone: one-year follow-up by MRI. Circ Cardiovasc Imaging 2009;2:47-55.
35. Appelbaum E, Abraham JM, Pride YB. Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Am Heart J 2009;158:84-91.
36. Kloner RA, Ganote CE, Jennings RB. The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-508.
37. Taylor AJ, Al-Saadi N, Abdel-Aty H. Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation 2004;109:2080-5.
38. Ibrahim T, Hackl T, Nekolla SG. Acute myocardial infarction: serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusion. Radiology 2010;254:88-97.
39. Bax JJ, Wijns W, Cornel JH. Accuracyofcurrently available techniques for prediction of functional recoveryafter revascularizationinpatientswith left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-60.